Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 12/20 | 0.53 |
| ▸ | CNR2 | P34972 | 5/20 | 0.43 |
| ▸ | CNR1 | P21554 | 2/20 | 0.40 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.39 |
| ▸ | NPY2R | P49146 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4000970 | 0.88 | F10 (0.66) | F10CNR2 | |
| SCHEMBL5506228 | 0.83 | NPY2R (0.41) | F10CNR2KCNQ2NPY2R | |
| SCHEMBL5505143 | 0.83 | F10 (0.53) | F10CNR2CNR1 | |
| SCHEMBL5511183 | 0.82 | NPC1 (0.41) | F10CNR2CNR1KCNQ2NPY2R | |
| SCHEMBL5505029 | 0.81 | WDR5 (0.41) | F10CNR2CNR1NPY2R | |
| SCHEMBL4465502 | 0.81 | F10 (0.69) | F10 | |
| SCHEMBL5502392 | 0.80 | F10 (0.43) | F10CNR2CNR1 | |
| SCHEMBL5509349 | 0.80 | F10 (0.43) | F10CNR2CNR1 | |
| SCHEMBL5504063 | 0.79 | F10 (0.42) | F10CNR2CNR1 | |
| SCHEMBL29653575 | 0.78 | F10 (0.62) | F10CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1747217-A1 | NOVEL SUBSTITUTED THIOPHENECARBOXAMIDES, THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS | Boehringer Ingelheim International GmbH (DE) | 2007-01-31 | — | — | EP | disclosed |
| WO-2005111029-A1 | NOVEL SUBSTITUTED THIOPHENECARBOXAMIDES, THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-11-24 | — | — | WO | disclosed |